Kiss1-/- mice exhibit more variable hypogonadism than Gpr54-/- mice.

The G protein-coupled receptor Gpr54 and its ligand metastin (derived from the Kiss1 gene product kisspeptin) are key gatekeepers of sexual maturation. Gpr54 knockout mice demonstrate hypogonadotropic hypogonadism, but until recently, the phenotype of Kiss1 knockout mice was unknown. This report describes the reproductive phenotypes of mice carrying targeted deletions of Kiss1 or Gpr54 on the same genetic background. Both Kiss1 and Gpr54 knockout mice are viable but infertile and have abnormal sexual maturation; the majority of males lack preputial separation, and females have delayed vaginal opening and absence of estrous cycling. Kiss1 and Gpr54 knockout males have significantly smaller testes compared with controls. Gpr54 knockout females have smaller ovaries and uteri than wild-type females. However, Kiss1 knockout females demonstrate two distinct phenotypes: half have markedly reduced gonadal weights similar to those of Gpr54 knockout mice, whereas half exhibit persistent vaginal cornification and have gonadal weights comparable with those of wild-type females. FSH levels in both Kiss1 and Gpr54 knockout males and females are significantly lower than in controls. When injected with mouse metastin 43-52, a Gpr54 agonist, Gpr54 knockout mice fail to increase gonadotropins, whereas Kiss1 knockout mice respond with increased gonadotropin levels. In summary, both Kiss1 and Gpr54 knockout mice have abnormal sexual maturation consistent with hypogonadotropic hypogonadism, although Kiss1 knockout mice appear to be less severely affected than their receptor counterparts. Kiss1 knockout females demonstrate a bimodal phenotypic variability, with some animals having higher gonadal weight, larger vaginal opening, and persistent vaginal cornification.

[1]  J. Hanoune Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. , 2007 .

[2]  M. Bilban,et al.  Kisspeptins and the placenta: Regulation of trophoblast invasion , 2007, Reviews in Endocrine and Metabolic Disorders.

[3]  N. de Roux,et al.  Neuroendocrine phenotype analysis in five patients with isolated hypogonadotropic hypogonadism due to a L102P inactivating mutation of GPR54. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  Rob Leurs,et al.  Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. , 2007, Annual review of pharmacology and toxicology.

[5]  A. Herbison,et al.  Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons. , 2006, Endocrinology.

[6]  G. Delsol,et al.  Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha , 2006, Neuroscience Letters.

[7]  R. Steiner,et al.  Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion. , 2006, Endocrinology.

[8]  R. Steiner,et al.  Regulation of Kiss1 gene expression in the brain of the female mouse. , 2005, Endocrinology.

[9]  R. Braun,et al.  Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse. , 2005, Endocrinology.

[10]  M. Justice,et al.  A novel mouse model of hypogonadotrophic hypogonadism: N-ethyl-N-nitrosourea-induced gonadotropin-releasing hormone receptor gene mutation. , 2005, Molecular endocrinology.

[11]  J Ellery,et al.  Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. , 2005, The Journal of clinical endocrinology and metabolism.

[12]  M. Poutanen,et al.  Testosterone replacement therapy induces spermatogenesis and partially restores fertility in luteinizing hormone receptor knockout mice. , 2005, Endocrinology.

[13]  M. Matzuk,et al.  Targeted disruption of luteinizing hormone beta-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  V. Quaranta,et al.  Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts , 2004, Journal of Cell Science.

[15]  F. Monsma,et al.  The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. , 2003, Biochemical and biophysical research communications.

[16]  S. O’Rahilly,et al.  The GPR54 Gene as a Regulator of Puberty , 2003 .

[17]  E. Génin,et al.  Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Schiffmann,et al.  The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-coupled Receptor GPR54* , 2001, The Journal of Biological Chemistry.

[19]  P. Emson,et al.  AXOR12, a Novel Human G Protein-coupled Receptor, Activated by the Peptide KiSS-1* , 2001, The Journal of Biological Chemistry.

[20]  O. Nishimura,et al.  Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor , 2001, Nature.

[21]  I. Huhtaniemi,et al.  The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. , 2000, Endocrinology.

[22]  A. Gansmuller,et al.  Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Matzuk,et al.  Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility , 1997, Nature Genetics.

[24]  J M Trent,et al.  KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. , 1996, Journal of the National Cancer Institute.

[25]  G. Hoffman,et al.  cFos immunoreactivity is enhanced with biotin amplification. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  F. V. vom Saal,et al.  Transport of steroids between fetuses via amniotic fluid in relation to the intrauterine position phenomenon in rats. , 1992, Journal of reproduction and fertility.

[27]  S. Wiegand,et al.  Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology , 1986, Peptides.

[28]  C. Finch,et al.  Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. , 1981, Biology of reproduction.

[29]  G. Fink,et al.  Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism , 1977, Nature.

[30]  H. Bern,et al.  Persistent Vaginal Cornification in Mice , 1962, Science.

[31]  C. Rao,et al.  Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. , 2001, Molecular endocrinology.

[32]  M. Poutanen,et al.  Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. , 2001, Molecular endocrinology.